Primary cutaneous B‐cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers
Marco Lucioni(University of Pavia), Marco Paulli(University of Milan), Maria Giuseppina Cabras(University of Cagliari), Luca Arcaini(University of Pavia), Sara Rattotti(Policlinico San Matteo Fondazione), Mauro Alaibac(University of Milan), Aldo Maffi(University of Pavia), Giorgio Alberto Croci(University of Pavia), Maria Teresa Fierro(University of Turin), Roberta Riboni(University of Pavia), Gaia Goteri(Marche Polytechnic University), Francesco Onida(Peter MacCallum Cancer Centre), Giulio Fraternali Orcioni(Martin University), Serena Rupoli(University of Milan), Silvia Franceschetti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Stefano Ascani(University of Perugia), Pietro Quaglino(Department of Medical Sciences), Catherine Klersy(AOL (United States)), Nicola Zerbinati(University of Insubria), Antonio Ramponi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Carlo Tomasini(European Organisation for Research and Treatment of Cancer), Vieri Grandi(Peter MacCallum Cancer Centre), Emilio Berti(Université de Bordeaux), Elena Dallera(University of Pavia), Pier Luigi Zinzani(University of Bologna), Mariarosa Arra(University of Pavia), Nicola Pimpinelli(University of Florence), Marcello Gambacorta(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marco Santucci(Okayama University)
Cited by 46
Related Papers
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657